AllergologyNews.net

Allergology Xagena

Exposure to household endotoxin levels poses a significant risk for asthma. The study appears in the American Journal of Respiratory and Critical Care Medicine. Endotoxins are toxic substances a ...


Researchers at the Johns Hopkins Children's Center have found that 9 percent of children allergic to almonds, pecans, cashews and other tree nuts outgrow their allergy over time, including those who'v ...


European Commission has granted marketing authorization in all 25 EU member states for the novel asthma therapy Xolair ( Omalizumab ). Xolair offers a unique therapeutic approach by blocking the ac ...


Long-term data show that Xolair ( Omalizumab ), a first-in-class monoclonal antibody for treating severe allergic asthma, helped patients to maintain control of their disease and was safe and well-tol ...


The Fda ( Food and Drug Administration ) has approved Singulair ( Montelukast ) for the relief of symptoms of perennial allergic rhinitis ( PAR ), or indoor allergies, in adults and children six month ...


Preliminary results of the clinical trial of CRX-675, a toll-like receptor 4 ( TLR4 ) agonist, in subjects allergic to ragweed showed that the drug is safe. The study was a randomized, blinded, pl ...


Data from seven clinical studies demonstrate that in patients with severe allergic asthma who require treatment with oral corticosteroids – indicating that they have a more severe form of the disease ...